Novel imantib resistance mechanisms in chronic myloid leukemia
In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findi...
Guardat en:
Autor principal: | |
---|---|
Altres autors: | |
Format: | Dissertation |
Idioma: | anglès |
Publicat: |
Philipps-Universität Marburg
2007
|
Matèries: | |
Accés en línia: | PDF a text complet |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
No citations were found for this record.